PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
03-Aug-2022 Veterinary Imaging Market Forecast 2030 | Size, Share, Growth & Forecast |Future Market Insights MARKITWIRED
03-Aug-2022 PD1/PDL1 Inhibitors Market Analysis by Type, Application, Growth, Demand, Status, and Forecast 2030 MARKITWIRED
03-Aug-2022 TME Pharma Announces Enrollment of First Patient in Pembrolizumab Expansion Arm of NOX-A12 GLORIA Phase 1/2 Brain Cancer Clinical Trial Businesswire
03-Aug-2022 U.S. Food and Drug Administration (FDA) approves FYB201/CIMERLITM* (ranibizumab-eqrn), the first and only biosimilar interchangeable with Lucentis®** Polpharma Biologics
03-Aug-2022 Ipsen Announces Results from Phase III RESILIENT Trial Evaluating Onivyde® in Second-Line Monotherapy for Small Cell Lung Cancer Businesswire
03-Aug-2022 U.S. Food and Drug Administration (FDA) approved FYB201/CIMERLITM1 (ranibizumab-eqrn), the first and only biosimilar interchangeable with Lucentis®2 Formycon AG
03-Aug-2022 Antibiotic Research UK Announces New CEO Sciad Newswire
03-Aug-2022 Formycon announces FDA approval of FYB201/CIMERLITM1 (ranibizumab-eqrn) as a Biosimilar interchangeable with Lucentis®2 Formycon AG
03-Aug-2022 Excimer and Femtosecond Ophthalmic Lasers Market is Expected to Rise at a CAGR of 5% Over the Forecast Period by 2026 MARKITWIRED
03-Aug-2022 Negative Pressure Wound Therapy Market is projected to grow at a steady CAGR of 5.2% during the forecast period by 2032 MARKITWIRED
03-Aug-2022 Neurointerventional Devices Market is expected to reach US$ 3.6 Billion by the end of 2030 MARKITWIRED
03-Aug-2022 Infection Prevention Market is projected to rise at a CAGR of 4.2% forecast period by 2031 MARKITWIRED
03-Aug-2022 Pelvic Floor Stimulators Market is estimated to grow at a CAGR of 8.8% during the forecast period by 2031 MARKITWIRED
03-Aug-2022 Relief Therapeutics Announces Promising Initial Stability Data on a New Formulation of RLF-100® (Aviptadil) Relief Therapeutics Holding SA
03-Aug-2022 Curia ernennt Niall Condon zum President seiner Produktionssparte Businesswire
02-Aug-2022 Bicycle Therapeutics Announces Publication of Article in Bioconjugate Chemistry, Describing an Extension of its Proprietary Technology Platform Based on Bicyclic Peptides Businesswire
02-Aug-2022 Revance to Release Second Quarter 2022 Financial Results on Tuesday, August 9, 2022 Businesswire
02-Aug-2022 Gilead Sciences Announces Second Quarter 2022 Financial Results Businesswire
02-Aug-2022 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of TuSimple Holdings Inc. (TSP) on Behalf of Investors Businesswire
02-Aug-2022 SpineGuard Announces the Revision of Its 2022 Financial Calendar Businesswire